Sensus Healthcare logo

Sensus HealthcareNASDAQ: SRTS

Profile

Sector:

Healthcare

Country:

United States

IPO:

26 July 2016

Next earnings report:

02 August 2024

Last dividends:

N/A

Next dividends:

N/A
$83.60 M
-66%vs. 3y high
42%vs. sector
-89%vs. 3y high
30%vs. sector
-78%vs. 3y high
51%vs. sector
-63%vs. 3y high
45%vs. sector

Price

after hours | Wed, 03 Jul 2024 20:49:15 GMT
$5.10+$0.04(+0.79%)

Dividend

No data over the past 3 years
$10.66 M$6.94 M
$10.66 M$2.27 M

Analysts recommendations

Institutional Ownership

SRTS Latest News

Sensus Healthcare, Inc. (SRTS) Stock Sinks As Market Gains: Here's Why
zacks.com25 June 2024 Sentiment: -

In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.87, marking a -1.81% move from the previous day.

Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors
zacks.com17 June 2024 Sentiment: -

Sensus Healthcare, Inc. (SRTS) closed at $5.22 in the latest trading session, marking a -1.51% move from the prior day.

Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade
zacks.com10 June 2024 Sentiment: -

Sensus Healthcare, Inc. (SRTS) concluded the recent trading session at $5.48, signifying a -0.54% move from its prior day's close.

Here's Why Momentum in Sensus Healthcare (SRTS) Should Keep going
zacks.com31 May 2024 Sentiment: POSITIVE

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare (SRTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Are Medical Stocks Lagging Sensus Healthcare (SRTS) This Year?
zacks.com30 May 2024 Sentiment: NEUTRAL

Here is how Sensus Healthcare, Inc. (SRTS) and Aileron Therapeutics, Inc. (ALRN) have performed compared to their sector so far this year.

Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript
Seeking Alpha08 February 2024 Sentiment: POSITIVE

Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript

Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates
Zacks Investment Research08 February 2024 Sentiment: POSITIVE

Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.17 per share a year ago.

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
GlobeNewsWire30 January 2024 Sentiment: POSITIVE

BOCA RATON, Fla. , Jan. 30, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and full year 2023. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

Sensus Healthcare, Inc. (SRTS) Q3 2023 Earnings Call Transcript
Seeking Alpha09 November 2023 Sentiment: POSITIVE

Sensus Healthcare, Inc. (SRTS) Q3 2023 Earnings Call Transcript

Sensus Healthcare, Inc (SRTS) Q2 2023 Earnings Call Transcript
Seeking Alpha06 August 2023 Sentiment: POSITIVE

Sensus Healthcare, Inc (NASDAQ:SRTS ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Kim Golodetz - IR Joseph Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO Conference Call Participants Scott Henry - ROTH Capital Anthony Vendetti - Maxim Group Ben Haynor - Alliance Global Partners Operator Welcome to the Sensus Healthcare Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded.

What type of business is Sensus Healthcare?

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

What sector is Sensus Healthcare in?

Sensus Healthcare is in the Healthcare sector

What industry is Sensus Healthcare in?

Sensus Healthcare is in the Medical Devices industry

What country is Sensus Healthcare from?

Sensus Healthcare is headquartered in United States

When did Sensus Healthcare go public?

Sensus Healthcare initial public offering (IPO) was on 26 July 2016

What is Sensus Healthcare website?

https://www.sensushealthcare.com

Is Sensus Healthcare in the S&P 500?

No, Sensus Healthcare is not included in the S&P 500 index

Is Sensus Healthcare in the NASDAQ 100?

No, Sensus Healthcare is not included in the NASDAQ 100 index

Is Sensus Healthcare in the Dow Jones?

No, Sensus Healthcare is not included in the Dow Jones index

When does Sensus Healthcare report earnings?

The next expected earnings date for Sensus Healthcare is 02 August 2024